Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 24 July 1998:
Vol. 281. no. 5376, pp. 533 - 538
DOI: 10.1126/science.281.5376.533
Prev | Table of Contents | Next

Reports

Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors

Nathanael S. Gray, Lisa Wodicka, Andy-Mark W. H. Thunnissen, Thea C. Norman, Soojin Kwon, F. Hernan Espinoza, David O. Morgan, Georjana Barnes, Sophie LeClerc, Laurent Meijer, Sung-Hou Kim, David J. Lockhart, Peter G. Schultz *

Selective protein kinase inhibitors were developed on the basis of the unexpected binding mode of 2,6,9-trisubstituted purines to the adenosine triphosphate-binding site of the human cyclin-dependent kinase 2 (CDK2). By iterating chemical library synthesis and biological screening, potent inhibitors of the human CDK2-cyclin A kinase complex and of Saccharomyces cerevisiae Cdc28p were identified. The structural basis for the binding affinity and selectivity was determined by analysis of a three-dimensional crystal structure of a CDK2-inhibitor complex. The cellular effects of these compounds were characterized in mammalian cells and yeast. In the latter case the effects were characterized on a genome-wide scale by monitoring changes in messenger RNA levels in treated cells with high-density oligonucleotide probe arrays. Purine libraries could provide useful tools for analyzing a variety of signaling and regulatory pathways and may lead to the development of new therapeutics.

N. S. Gray, T. C. Norman, S. Kwon, P. G. Schultz, Howard Hughes Medical Institute, University of California, Berkeley, CA 94720, USA. L. Wodicka and D. J. Lockhart, Affymetrix, 3380 Central Expressway, Santa Clara, CA 95051, USA. A.-M. W. H. Thunnissen and S.-H. Kim, Lawrence Berkeley National Laboratory and Department of Chemistry, University of California, Berkeley, CA 94720, USA. F. Hernan Espinoza and D. O. Morgan, Department of Physiology, University of California, San Francisco, CA 94143-0444, USA. G. Barnes, Department of Molecular and Cellular Biology, University of California, Berkeley, CA 94720, USA. S. LeClerc and L. Meijer, CNRS, Station Biologique, 29682 Roscoff, France.
*   To whom correspondence should be addressed.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Cytoplasmic initiation of cisplatin cytotoxicity.
F. Yu, J. Megyesi, and P. M. Price (2008)
Am J Physiol Renal Physiol 295, F44-F52
   Abstract »    Full Text »    PDF »
Cell polarization during monopolar cytokinesis.
C.-K. Hu, M. Coughlin, C. M. Field, and T. J. Mitchison (2008)
J. Cell Biol. 181, 195-202
   Abstract »    Full Text »    PDF »
Cdk1 phosphorylation of BubR1 controls spindle checkpoint arrest and Plk1-mediated formation of the 3F3/2 epitope.
O. K. Wong and G. Fang (2007)
J. Cell Biol. 179, 611-617
   Abstract »    Full Text »    PDF »
Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT.
J.-I Chao, W.-C. Su, and H.-F. Liu (2007)
Mol. Cancer Ther. 6, 3039-3048
   Abstract »    Full Text »    PDF »
Involvement of the CDK2-E2F1 pathway in cisplatin cytotoxicity in vitro and in vivo.
F. Yu, J. Megyesi, R. L. Safirstein, and P. M. Price (2007)
Am J Physiol Renal Physiol 293, F52-F59
   Abstract »    Full Text »    PDF »
Classical Anticytokinins Do Not Interact with Cytokinin Receptors but Inhibit Cyclin-dependent Kinases.
L. Spichal, V. Krystof, M. Paprskarova, R. Lenobel, J. Styskala, P. Binarova, V. Cenklova, L. De Veylder, D. Inze, G. Kontopidis, et al. (2007)
J. Biol. Chem. 282, 14356-14363
   Abstract »    Full Text »    PDF »
"Plate Cherry Picking": A Novel Semi-Sequential Screening Paradigm for Cheaper, Faster, Information-Rich Compound Selection.
T. J. Crisman, J. L. Jenkins, C. N. Parker, W. A. G. Hill, A. Bender, Z. Deng, J. H. Nettles, J. W. Davies, and M. Glick (2007)
J Biomol Screen 12, 320-327
   Abstract »    PDF »
Dependence of Cisplatin-Induced Cell Death In Vitro and In Vivo on Cyclin-Dependent Kinase 2.
P. M. Price, F. Yu, P. Kaldis, E. Aleem, G. Nowak, R. L. Safirstein, and J. Megyesi (2006)
J. Am. Soc. Nephrol. 17, 2434-2442
   Abstract »    Full Text »    PDF »
Selective Inhibitors of Bacterial DNA Adenine Methyltransferases.
N. Mashhoon, C. Pruss, M. Carroll, P. H. Johnson, and N. O. Reich (2006)
J Biomol Screen 11, 497-510
   Abstract »    PDF »
Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy.
Y. K. Lee, C. R. Isham, S. H. Kaufman, and K. C. Bible (2006)
Mol. Cancer Ther. 5, 138-148
   Abstract »    Full Text »    PDF »
CDK Phosphorylation Inhibits the DNA-binding and ATP-hydrolysis Activities of the Drosophila Origin Recognition Complex.
D. Remus, M. Blanchette, D. C. Rio, and M. R. Botchan (2005)
J. Biol. Chem. 280, 39740-39751
   Abstract »    Full Text »    PDF »
Depletion of Chk1 Leads to Premature Activation of Cdc2-cyclin B and Mitotic Catastrophe.
H. Niida, S. Tsuge, Y. Katsuno, A. Konishi, N. Takeda, and M. Nakanishi (2005)
J. Biol. Chem. 280, 39246-39252
   Abstract »    Full Text »    PDF »
Identification of an Inactivating Cysteine Switch in Protein Kinase C{varepsilon}, a Rational Target for the Design of Protein Kinase C{varepsilon}-Inhibitory Cancer Therapeutics.
F. Chu, J. M. Koomen, R. Kobayashi, and C. A. O'Brian (2005)
Cancer Res. 65, 10478-10485
   Abstract »    Full Text »    PDF »
Roscovitine Targets, Protein Kinases and Pyridoxal Kinase.
S. Bach, M. Knockaert, J. Reinhardt, O. Lozach, S. Schmitt, B. Baratte, M. Koken, S. P. Coburn, L. Tang, T. Jiang, et al. (2005)
J. Biol. Chem. 280, 31208-31219
   Abstract »    Full Text »    PDF »
Activation of p53-Dependent Apoptosis by Acute Ablation of Glycogen Synthase Kinase-3{beta} in Colorectal Cancer Cells.
J. C. Ghosh and D. C. Altieri (2005)
Clin. Cancer Res. 11, 4580-4588
   Abstract »    Full Text »    PDF »
Chemical genomic profiling to identify intracellular targets of a multiplex kinase inhibitor.
C. Kung, D. M. Kenski, S. H. Dickerson, R. W. Howson, L. F. Kuyper, H. D. Madhani, and K. M. Shokat (2005)
PNAS 102, 3587-3592
   Abstract »    Full Text »    PDF »
Alteration of Lithium Pharmacology through Manipulation of Phosphoadenosine Phosphate Metabolism.
B. D. Spiegelberg, J. dela Cruz, T.-H. Law, and J. D. York (2005)
J. Biol. Chem. 280, 5400-5405
   Abstract »    Full Text »    PDF »
An integrated tool for microarray data clustering and cluster validity assessment.
N. Bolshakova, F. Azuaje, and Pád. Cunningham (2005)
Bioinformatics 21, 451-455
   Abstract »    Full Text »    PDF »
Roscovitine Inhibits Activation of Promoters in Herpes Simplex Virus Type 1 Genomes Independently of Promoter-Specific Factors.
P. Diwan, J. J. Lacasse, and L. M. Schang (2004)
J. Virol. 78, 9352-9365
   Abstract »    Full Text »    PDF »
Inhibitors of Leishmania mexicana CRK3 Cyclin-Dependent Kinase: Chemical Library Screen and Antileishmanial Activity.
K. M. Grant, M. H. Dunion, V. Yardley, A.-L. Skaltsounis, D. Marko, G. Eisenbrand, S. L. Croft, L. Meijer, and J. C. Mottram (2004)
Antimicrob. Agents Chemother. 48, 3033-3042
   Abstract »    Full Text »    PDF »
Identification of Vasoactive Nonpeptidic Positive and Negative Modulators of Adrenomedullin Using a Neutralizing Antibody-Based Screening Strategy.
A. MartInez, M. Julian, C. Bregonzio, L. Notari, T. W. Moody, and F. Cuttitta (2004)
Endocrinology 145, 3858-3865
   Abstract »    Full Text »    PDF »
Mathematical algorithm for discovering states of expression from direct genetic comparison by microarrays.
H. M. Fathallah-Shaykh, B. He, L.-J. Zhao, and A. Badruddin (2004)
Nucleic Acids Res. 32, 3807-3814
   Abstract »    Full Text »    PDF »
Down-regulation of Survivin in Nitric Oxide-induced Cell Growth Inhibition and Apoptosis of the Human Lung Carcinoma Cells.
J.-I Chao, P.-C. Kuo, and T.-S. Hsu (2004)
J. Biol. Chem. 279, 20267-20276
   Abstract »    Full Text »    PDF »
Cassette dosing pharmacokinetics of a library of 2,6,9-trisubstituted purine cyclin-dependent kinase 2 inhibitors prepared by parallel synthesis.
F. I. Raynaud, P. M. Fischer, B. P. Nutley, P. M. Goddard, D. P. Lane, and P. Workman (2004)
Mol. Cancer Ther. 3, 353-362
   Abstract »    Full Text »
Inhibition of S-Phase Cyclin-Dependent Kinase Activity Blocks Expression of Epstein-Barr Virus Immediate-Early and Early Genes, Preventing Viral Lytic Replication.
A. Kudoh, T. Daikoku, Y. Sugaya, H. Isomura, M. Fujita, T. Kiyono, Y. Nishiyama, and T. Tsurumi (2004)
J. Virol. 78, 104-115
   Abstract »    Full Text »    PDF »
The Cyclin-dependent Kinase Inhibitor CYC202 (R-Roscovitine) Inhibits Retinoblastoma Protein Phosphorylation, Causes Loss of Cyclin D1, and Activates the Mitogen-activated Protein Kinase Pathway.
S. R. Whittaker, M. I. Walton, M. D. Garrett, and P. Workman (2004)
Cancer Res. 64, 262-272
   Abstract »    Full Text »    PDF »
Identification of Selective Inhibitors of NAD+-dependent Deacetylases Using Phenotypic Screens in Yeast.
M. Hirao, J. Posakony, M. Nelson, H. Hruby, M. Jung, J. A. Simon, and A. Bedalov (2003)
J. Biol. Chem. 278, 52773-52782
   Abstract »    Full Text »    PDF »
{alpha}v{beta}3 integrin expression up-regulates cdc2, which modulates cell migration.
T. Manes, D.-Q. Zheng, S. Tognin, A. S. Woodard, P. C. Marchisio, and L. R. Languino (2003)
J. Cell Biol. 161, 817-826
   Abstract »    Full Text »    PDF »
Selective Cyclin-dependent Kinase 2/Cyclin A Antagonists that Differ from ATP Site Inhibitors Block Tumor Growth.
N. Mendoza, S. Fong, J. Marsters, H. Koeppen, R. Schwall, and D. Wickramasinghe (2003)
Cancer Res. 63, 1020-1024
   Abstract »    Full Text »    PDF »
Identification of Homeodomain Proteins, PBX1 and PREP1, Involved in the Transcription of Murine Leukemia Virus.
S.-H. Chao, J. R. Walker, S. K. Chanda, N. S. Gray, and J. S. Caldwell (2003)
Mol. Cell. Biol. 23, 831-841
   Abstract »    Full Text »
Flavopiridol-related Proinflammatory Syndrome Is Associated with Induction of Interleukin-6.
R. A. Messmann, C. D. Ullmann, T. Lahusen, A. Kalehua, J. Wasfy, G. Melillo, I. Ding, D. Headlee, W. D. Figg, E. A. Sausville, et al. (2003)
Clin. Cancer Res. 9, 562-570
   Abstract »    Full Text »    PDF »
Inhibition of Protein Kinase CK2 by Anthraquinone-related Compounds. A STRUCTURAL INSIGHT.
E. De Moliner, S. Moro, S. Sarno, G. Zagotto, G. Zanotti, L. A. Pinna, and R. Battistutta (2003)
J. Biol. Chem. 278, 1831-1836
   Abstract »    Full Text »    PDF »
Cyclin-dependent kinases as cellular targets for antiviral drugs.
L. M. Schang (2002)
J. Antimicrob. Chemother. 50, 779-792
   Abstract »    Full Text »    PDF »
Phase I Clinical and Pharmacokinetic Study of Flavopiridol Administered as a Daily 1-Hour Infusion in Patients With Advanced Neoplasms.
A. R. Tan, D. Headlee, R. Messmann, E. A. Sausville, S. G. Arbuck, A. J. Murgo, G. Melillo, S. Zhai, W. D. Figg, S. M. Swain, et al. (2002)
J. Clin. Oncol. 20, 4074-4082
   Abstract »    Full Text »    PDF »
CH{middle dot}{middle dot}{middle dot}O Hydrogen Bonds at Protein-Protein Interfaces.
L. Jiang and L. Lai (2002)
J. Biol. Chem. 277, 37732-37740
   Abstract »    Full Text »    PDF »
The Cell Cycle as a Target for Cancer Therapy: Basic and Clinical Findings with the Small Molecule Inhibitors Flavopiridol and UCN-01.
A. M. Senderowicz (2002)
Oncologist 7, 12-19
   Abstract »    Full Text »    PDF »
Intracellular Targets of Paullones. IDENTIFICATION FOLLOWING AFFINITY PURIFICATION ON IMMOBILIZED INHIBITOR.
M. Knockaert, K. Wieking, S. Schmitt, M. Leost, K. M. Grant, J. C. Mottram, C. Kunick, and L. Meijer (2002)
J. Biol. Chem. 277, 25493-25501
   Abstract »    Full Text »    PDF »
Pharmacological Cyclin-Dependent Kinase Inhibitors Inhibit Replication of Wild-Type and Drug-Resistant Strains of Herpes Simplex Virus and Human Immunodeficiency Virus Type 1 by Targeting Cellular, Not Viral, Proteins.
L. M. Schang, A. Bantly, M. Knockaert, F. Shaheen, L. Meijer, M. H. Malim, N. S. Gray, and P. A. Schaffer (2002)
J. Virol. 76, 7874-7882
   Abstract »    Full Text »    PDF »
A Novel, Extraneuronal Role for Cyclin-dependent Protein Kinase 5 (CDK5). MODULATION OF cAMP-INDUCED APOPTOSIS IN RAT LEUKEMIA CELLS.
T. Sandal, C. Stapnes, H. Kleivdal, L. Hedin, and S. O. Doskeland (2002)
J. Biol. Chem. 277, 20783-20793
   Abstract »    Full Text »    PDF »
Selective Inhibition of MAPKK Wis1 in the Stress-activated MAPK Cascade of Schizosaccharomyces pombe by Novel Berberine Derivatives.
M. J. Jang, M. Jwa, J.-H. Kim, and K. Song (2002)
J. Biol. Chem. 277, 12388-12395
   Abstract »    Full Text »    PDF »
High Throughput Studies of Gene Expression Using Green Fluorescent Protein-Oxidative Stress Promoter Probe Constructs The Potential for Living Chips.
C. R. Albano, C. Lu, W. E. Bentley, and G. Rao (2001)
J Biomol Screen 6, 421-428
   Abstract »    PDF »
Characterization of a Human Colorectal Carcinoma Cell Line with Acquired Resistance to Flavopiridol.
V. Smith, F. Raynaud, P. Workman, and L. R. Kelland (2001)
Mol. Pharmacol. 60, 885-893
   Abstract »    Full Text »    PDF »
Cell cycle-dependent control of polarised development by a cyclin-dependent kinase-like protein in the Fucus zygote.
F. Corellou, C. Brownlee, B. Kloareg, and F.-Y. Bouget (2001)
Development 128, 4383-4392
   Abstract »    Full Text »    PDF »
Inhibition of Human Immunodeficiency Virus Type 1 Transcription by Chemical Cyclin-Dependent Kinase Inhibitors.
D. Wang, C. de la Fuente, L. Deng, L. Wang, I. Zilberman, C. Eadie, M. Healey, D. Stein, T. Denny, L. E. Harrison, et al. (2001)
J. Virol. 75, 7266-7279
   Abstract »    Full Text »    PDF »
c-Myc Is Necessary for DNA Damage-Induced Apoptosis in the G2 Phase of the Cell Cycle.
S. Adachi, A. J. Obaya, Z. Han, N. Ramos-Desimone, J. H. Wyche, and J. M. Sedivy (2001)
Mol. Cell. Biol. 21, 4929-4937
   Abstract »    Full Text »    PDF »
A Novel cdk2-selective Inhibitor, SU9516, Induces Apoptosis in Colon Carcinoma Cells.
M. E. Lane, B. Yu, A. Rice, K. E. Lipson, C. Liang, L. Sun, C. Tang, G. McMahon, R. G. Pestell, and S. Wadler (2001)
Cancer Res. 61, 6170-6177
   Abstract »    Full Text »    PDF »
Microarrays for microbiologists.
S. Lucchini, A. Thompson, and J. C. D. Hinton (2001)
Microbiology 147, 1403-1414
   Full Text »    PDF »
Expression Profiling of Neural Cells Reveals Specific Patterns of Ethanol-Responsive Gene Expression.
C. Thibault, C. Lai, N. Wilke, B. Duong, M. F. Olive, S. Rahman, H. Dong, C. W. Hodge, D. J. Lockhart, and M. F. Miles (2001)
Mol. Pharmacol. 58, 1593-1600
   Abstract »    Full Text »
In Vivo Metabolism of 2,6,9-Trisubstituted Purine-Derived Cyclin-Dependent Kinase Inhibitor Bohemine in Mice: Glucosidation as the Principal Metabolic Route.
J. Veselý, K. Lemr, M. Rypka, and L. Michnová (2001)
Drug Metab. Dispos. 29, 326-334
   Abstract »    Full Text »
Induction of Host Gene Expression following Infection of Chicken Embryo Fibroblasts with Oncogenic Marek's Disease Virus.
R. W. Morgan, L. Sofer, A. S. Anderson, E. L. Bernberg, J. Cui, and J. Burnside (2001)
J. Virol. 75, 533-539
   Abstract »    Full Text »
New Components of a System for Phosphate Accumulation and Polyphosphate Metabolism in Saccharomyces cerevisiae Revealed by Genomic Expression Analysis.
N. Ogawa, J. DeRisi, and P. O. Brown (2000)
Mol. Biol. Cell 11, 4309-4321
   Abstract »    Full Text »
Large-Scale Profiling of the Arabidopsis Transcriptome.
T. Zhu and X. Wang (2000)
Plant Physiology 124, 1472-1476
   Full Text »
End-specific covalent photo-dependent immobilisation of synthetic DNA to paramagnetic beads.
R. Penchovsky, E. Birch-Hirschfeld, and J. S. McCaskill (2000)
Nucleic Acids Res. 28, e98
   Abstract »    Full Text »    PDF »
Inhibition of Cyclin-Dependent Kinase Activity and Induction of Apoptosis by Preussin in Human Tumor Cells.
T. V. Achenbach, E. P. Slater, H. Brummerhop, T. Bach, and R. Müller (2000)
Antimicrob. Agents Chemother. 44, 2794-2801
   Abstract »    Full Text »
p16Ink4a Tumor Suppressor Function in Lung Cancer Cells Involves Cyclin-dependent Kinase 2 Inhibition by Cip/Kip Protein Redistribution.
B. Grimison, T. A. Langan, and R. A. Sclafani (2000)
Cell Growth Differ. 11, 507-515
   Abstract »    Full Text »
Monitoring the Expression Profiles of Doxorubicin-induced and Doxorubicin-resistant Cancer Cells by cDNA Microarray.
K. Kudoh, M. Ramanna, R. Ravatn, A. G. Elkahloun, M. L. Bittner, P. S. Meltzer, J. M. Trent, W. S. Dalton, and K.-V. Chin (2000)
Cancer Res. 60, 4161-4166
   Abstract »    Full Text »
A miniature integrated device for automated multistep genetic assays.
R. C. Anderson, X. Su, G. J. Bogdan, and J. Fenton (2000)
Nucleic Acids Res. 28, e60
   Abstract »    Full Text »    PDF »
Combinatorial Chemistry and Contemporary Pharmacology.
J. S. Lazo and P. Wipf (2000)
J. Pharmacol. Exp. Ther. 293, 705-709
   Abstract »    Full Text »
Pneumocystis carinii Uses a Functional Cdc13 B-Type Cyclin Complex during Its Life Cycle.
T. J. Kottom, C. F. Thomas Jr., K. K. Mubarak, E. B. Leof, and A. H. Limper (2000)
Am. J. Respir. Cell Mol. Biol. 22, 722-731
   Abstract »    Full Text »
Flavopiridol Binds to Duplex DNA.
K. C. Bible, R. H. Bible Jr., T. J. Kottke, P. A. Svingen, K. Xu, Y.-P. Pang, E. Hajdu, and S. H. Kaufmann (2000)
Cancer Res. 60, 2419-2428
   Abstract »    Full Text »
Monitoring Cellular Responses to Listeria monocytogenes with Oligonucleotide Arrays.
P. Cohen, M. Bouaboula, M. Bellis, V. Baron, O. Jbilo, C. Poinot-Chazel, S. Galiegue, E.-H. Hadibi, and P. Casellas (2000)
J. Biol. Chem. 275, 11181-11190
   Abstract »    Full Text »    PDF »
Recent advances in molecular biological techniques and their relevance to pulmonary research.
B W S Robinson, D J Erle, D A Jones, S Shapiro, W J Metzger, S M Albelda, W C Parks, and A Boylan (2000)
Thorax 55, 329-339
   Full Text »
Activation of a Plasmodium falciparum cdc2-related Kinase by Heterologous p25 and Cyclin H. FUNCTIONAL CHARACTERIZATION OF A P. FALCIPARUM CYCLIN HOMOLOGUE.
K. Le Roch, C. Sestier, D. Dorin, N. Waters, B. Kappes, D. Chakrabarti, L. Meijer, and C. Doerig (2000)
J. Biol. Chem. 275, 8952-8958
   Abstract »    Full Text »    PDF »
Harnessing the Power of the Genome in the Search for New Antibiotics.
J. Rosamond and A. Allsop (2000)
Science 287, 1973-1976
   Abstract »    Full Text »
Combinatorial target-guided ligand assembly: Identification of potent subtype-selective c-Src inhibitors.
D. J. Maly, I. C. Choong, and J. A. Ellman (2000)
PNAS 97, 2419-2424
   Abstract »    Full Text »    PDF »
Preclinical and Clinical Development of Cyclin-Dependent Kinase Modulators.
A. M. Senderowicz and E. A. Sausville (2000)
J Natl Cancer Inst 92, 376-387
   Abstract »    Full Text »    PDF »
Systemic Administration of Calmodulin Antagonist W-7 or Protein Kinase A Inhibitor H-8 Prevents Torsade de Pointes in Rabbits.
A. Mazur, D. M. Roden, and M. E. Anderson (1999)
Circulation 100, 2437-2442
   Abstract »    Full Text »    PDF »
The p16 Status of Tumor Cell Lines Identifies Small Molecule Inhibitors Specific for Cyclin-dependent Kinase 4.
A. Kubo, K. Nakagawa, R. K. Varma, N. K. Conrad, J. Q. Cheng, W.-C. Lee, J. R. Testa, B. E. Johnson, F. J. Kaye, and M. J. Kelley (1999)
Clin. Cancer Res. 5, 4279-4286
   Abstract »    Full Text »    PDF »
Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells.
A. R. Karpf, P. W. Peterson, J. T. Rawlins, B. K. Dalley, Q. Yang, H. Albertsen, and D. A. Jones (1999)
PNAS 96, 14007-14012
   Abstract »    Full Text »    PDF »
Antifungal Activities of Antineoplastic Agents: Saccharomyces cerevisiae as a Model System To Study Drug Action.
M. E. Cardenas, M. C. Cruz, M. Del Poeta, N. Chung, J. R. Perfect, and J. Heitman (1999)
Clin. Microbiol. Rev. 12, 583-611
   Abstract »    Full Text »    PDF »
Functional genomics.
S. Fields, Y. Kohara, and D. J. Lockhart (1999)
PNAS 96, 8825-8826
   Abstract »    Full Text »    PDF »
Discovery and Initial Characterization of the Paullones, a Novel Class of Small-Molecule Inhibitors of Cyclin-dependent Kinases.
D. W. Zaharevitz, R. Gussio, M. Leost, A. M. Senderowicz, T. Lahusen, C. Kunick, L. Meijer, and E. A. Sausville (1999)
Cancer Res. 59, 2566-2569
   Abstract »    Full Text »    PDF »
A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: Biochemical identification using Xenopus egg extracts.
G. R. Rosania, J. Merlie Jr., N. Gray, Y.-T. Chang, P. G. Schultz, and R. Heald (1999)
PNAS 96, 4797-4802
   Abstract »    Full Text »    PDF »
Intra-M Phase-promoting Factor Phosphorylation of Cyclin B at the Prophase/Metaphase Transition.
A. Borgne, A. C. Ostvold, S. Flament, and L. Meijer (1999)
J. Biol. Chem. 274, 11977-11986
   Abstract »    Full Text »    PDF »
Chloroquine Binds in the Cofactor Binding Site of Plasmodium falciparum Lactate Dehydrogenase.
J. A. Read, K. W. Wilkinson, R. Tranter, R. B. Sessions, and R. L. Brady (1999)
J. Biol. Chem. 274, 10213-10218
   Abstract »    Full Text »    PDF »
The Genexpress IMAGE Knowledge Base of the Human Brain Transcriptome: A Prototype Integrated Resource for Functional and Computational Genomics.
G. Piétu, R. Mariage-Samson, N.-A. Fayein, C. Matingou, E. Eveno, R. Houlgatte, C. Decraene, Y. Vandenbrouck, F. Tahi, M.-D. Devignes, et al. (1999)
Genome Res. 9, 195-209
   Abstract »    Full Text »
A theory for controlling cell cycle dynamics using a reversibly binding inhibitor.
T. S. Gardner, M. Dolnik, and J. J. Collins (1998)
PNAS 95, 14190-14195
   Abstract »    Full Text »    PDF »
Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication.
S.-H. Chao, K. Fujinaga, J. E. Marion, R. Taube, E. A. Sausville, A. M. Senderowicz, B. M. Peterlin, and D. H. Price (2000)
J. Biol. Chem. 275, 28345-28348
   Abstract »    Full Text »    PDF »
Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis.
D. E. Joyce, L. Gelbert, A. Ciaccia, B. DeHoff, and B. W. Grinnell (2001)
J. Biol. Chem. 276, 11199-11203
   Abstract »    Full Text »    PDF »
Indirubins Inhibit Glycogen Synthase Kinase-3beta and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's Disease. A PROPERTY COMMON TO MOST CYCLIN-DEPENDENT KINASE INHIBITORS?.
S. Leclerc, M. Garnier, R. Hoessel, D. Marko, J. A. Bibb, G. L. Snyder, P. Greengard, J. Biernat, Y.-Z. Wu, E.-M. Mandelkow, et al. (2001)
J. Biol. Chem. 276, 251-260
   Abstract »    Full Text »    PDF »
Inhibition of NF-kappa B Activation by Arsenite through Reaction with a Critical Cysteine in the Activation Loop of Ikappa B Kinase.
P. Kapahi, T. Takahashi, G. Natoli, S. R. Adams, Y. Chen, R. Y. Tsien, and M. Karin (2000)
J. Biol. Chem. 275, 36062-36066
   Abstract »    Full Text »    PDF »
Strength of the Calpha H{middle dot}{middle dot}O Hydrogen Bond of Amino Acid Residues.
S. Scheiner, T. Kar, and Y. Gu (2001)
J. Biol. Chem. 276, 9832-9837
   Abstract »    Full Text »    PDF »
Crystallographic Approach to Identification of Cyclin-dependent Kinase 4 (CDK4)-specific Inhibitors by Using CDK4 Mimic CDK2 Protein.
M. Ikuta, K. Kamata, K. Fukasawa, T. Honma, T. Machida, H. Hirai, I. Suzuki-Takahashi, T. Hayama, and S. Nishimura (2001)
J. Biol. Chem. 276, 27548-27554
   Abstract »    Full Text »    PDF »
Flavopiridol Inactivates P-TEFb and Blocks Most RNA Polymerase II Transcription in Vivo.
S.-H. Chao and D. H. Price (2001)
J. Biol. Chem. 276, 31793-31799
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)